
Line
|

Candle
1D
5D
1M
3M
6M
YTD
1Y
5Y
High
14.793
Open
14.710
VWAP
14.50
Vol
70.01K
Mkt Cap
1.36B
Low
14.4108
Amount
1.02M
EV/EBITDA(TTM)
6.69
Total Shares
88.06M
EV
1.72B
EV/OCF(TTM)
6.56
P/S(TTM)
2.22
Afya Ltd is a Brazil-based company engaged in the education sector. The Company is mainly focused on operating medical schools, offering health sciences courses, which comprise medicine, dentistry, nursing, radiology, psychology, pharmacy, physical education, physiotherapy, nutrition and biomedicine. In addition, the Firm provides degree programs and courses in other subjects and disciplines, including undergraduate and post graduate courses in business administration, accounting, law, civil engineering, industrial engineering and pedagogy. The Company's methodological approach combines integrated content, interactive learning, and an adaptive experience for learners. Through its educational content and technology-enabled activities, the Company focuses on personalized learning that mirrors one-on-one tutoring. The Company's undergraduate and graduate campuses are spread across Brazil, as well as its digital medical platform.
Show More
Market Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2025Q2
FY2025Q3
FY2025Q4
936.22M
+15.6%
2.287
-0.13%
937.04M
+11.4%
1.928
+7.73%
931.83M
+9.75%
2.105
+0.25%
Estimates Revision
The market is revising Upward the revenue expectations for Afya Limited (AFYA) for FY2025, with the revenue forecasts being adjusted by 0.64% over the past three months. During the same period, the stock price has changed by -22.66%.
Revenue Estimates for FY2025
Revise Upward

+0.64%
In Past 3 Month
EPS Estimates for FY2025
Revise Upward

+2.41%
In Past 3 Month
Stock Price
Go Down

-22.66%
In Past 3 Month
3 Analyst Rating

42.85% Upside
Wall Street analysts forecast AFYA stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for AFYA is 20.67 USD with a low forecast of 19.00 USD and a high forecast of 23.50 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
0 Buy
2 Hold
1 Sell
Moderate Sell

42.85% Upside
Current: 14.470

Low
19.00
Averages
20.67
High
23.50

42.85% Upside
Current: 14.470

Low
19.00
Averages
20.67
High
23.50
UBS
Neutral
maintain
2025-06-12
Reason
UBS
Price Target
2025-06-12
maintain
Neutral
Reason
UBS raised the firm's price target on Afya to $19.50 from $17.50 and keeps a Neutral rating on the shares. Positive momentum on growth and margins seems fairly priced in, the analyst tells investors in a research note.
Morgan Stanley
Mauricio Cepeda
Hold
to
Sell
Downgrades
$19 → $17
2025-03-11
Reason
Morgan Stanley
Mauricio Cepeda
Price Target
$19 → $17
2025-03-11
Downgrades
Hold
to
Sell
Reason
Citigroup
Leandro Bastos
Hold
to
Strong Sell
Downgrades
$18 → $15
2025-01-31
Reason
Citigroup
Leandro Bastos
Price Target
$18 → $15
2025-01-31
Downgrades
Hold
to
Strong Sell
Reason
JP Morgan
Marcelo Santos
Hold
Maintains
$25 → $21
2025-01-17
Reason
JP Morgan
Marcelo Santos
Price Target
$25 → $21
2025-01-17
Maintains
Hold
Reason
Goldman Sachs
Gustavo Miele
Strong Sell
Initiates
$16
2024-12-03
Reason
Goldman Sachs
Gustavo Miele
Price Target
$16
2024-12-03
Initiates
Strong Sell
Reason
Goldman Sachs initiated coverage of Afya with a Sell rating and $16 price target. Afya is the largest medical education ecosystem in Brazil, the analyst tells investors in a research note. The firm says Afya's integration skills, solid brands, scale and relatively light balance sheet position the company as the main consolidator in the market, but it remains cautious on the economics of undergrad medical seats. AFYA's valuation premium to the rest of the sector is stretched at current levels, contends Goldman.
UBS
Andre Salles
Hold
Initiates
$20
2024-08-30
Reason
UBS
Andre Salles
Price Target
$20
2024-08-30
Initiates
Hold
Reason
See All Ratings
Valuation Metrics
The current forward P/E ratio for Afya Ltd (AFYA.O) is 8.65, compared to its 5-year average forward P/E of 15.67. For a more detailed relative valuation and DCF analysis to assess Afya Ltd 's fair value, click here.
Forward PE
The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

Undervalued
5Y Average PE
15.67
Current PE
8.65
Overvalued PE
22.53
Undervalued PE
8.81
Forward EV/EBITDA
The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

Undervalued
5Y Average EV/EBITDA
9.60
Current EV/EBITDA
5.41
Overvalued EV/EBITDA
13.67
Undervalued EV/EBITDA
5.53
Forward PS
The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

Fair
5Y Average PS
3.61
Current PS
1.91
Overvalued PS
5.72
Undervalued PS
1.51
Financials
Annual
Quarterly
FY2025Q1
YoY :
+16.43%
936.36M
Total Revenue
FY2025Q1
YoY :
+28.74%
372.53M
Operating Profit
FY2025Q1
YoY :
+23.40%
257.04M
Net Income after Tax
FY2025Q1
YoY :
+24.32%
2.76
EPS - Diluted
FY2025Q1
YoY :
+25.44%
407.64M
Free Cash Flow
FY2025Q1
YoY :
+5.01%
69.82
Gross Profit Margin - %
FY2025Q1
YoY :
+15.81%
32.67
FCF Margin - %
FY2025Q1
YoY :
+5.98%
27.45
Net Margin - %
FY2025Q1
YoY :
+14.48%
14.86
ROIC
Trading Trends
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
0-3
Months
0.0
Volume
0
3-6
Months
0.0
Volume
0
6-9
Months
0.0
Volume
0
0-12
Months
0.0
Volume
0
Bought
0-3
0
0.0
Volume
Months
3-6
1
918.9K
Volume
Months
6-9
1
1.8M
Volume
Months
0-12
1
1.8M
Volume
Months
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
AFYA News & Events
Events Timeline
2025-03-13 (ET)
2025-03-13
17:51:43
Afya sees FY25 revenue R$3.67B-R$3.77B

2025-03-13
17:50:05
Afya reports Q4 adjusted EPS R$2.10 vs. R$1.79 last year

2024-11-13 (ET)
2024-11-13
16:53:21
Afya backs FY24 revenue view R$3.23B-R$3.33B

Sign Up For More Events
Sign Up For More Events
News
7.5
07-22NewsfilterAfya Limited Releases 2024 Sustainability Report
2.0
07-22Yahoo FinanceAfya Limited Releases 2024 Sustainability Report
3.0
07-21NASDAQ.COMBest Growth Stocks to Buy for July 21st
Sign Up For More News
People Also Watch

SDGR
Schrodinger Inc
22.230
USD
-1.16%

KLG
WK Kellogg Co
23.140
USD
+0.04%

QCRH
QCR Holdings Inc
75.330
USD
+1.33%

HLX
Helix Energy Solutions Group Inc
6.170
USD
+3.01%

FSCO
FS Credit Opportunities Corp
7.420
USD
-0.27%

LBRDA
Liberty Broadband Corp
70.060
USD
-19.14%

VTLE
Vital Energy Inc
18.580
USD
-0.80%

WINA
Winmark Corp
383.200
USD
+0.75%

EVEX
Eve Holding Inc
6.960
USD
-3.33%

DCOM
Dime Community Bancshares Inc
28.340
USD
+0.18%
FAQ

What is Afya Ltd (AFYA) stock price today?
The current price of AFYA is 14.47 USD — it has decreased -1.09 % in the last trading day.

What is Afya Ltd (AFYA)'s business?

What is the price predicton of AFYA Stock?

What is Afya Ltd (AFYA)'s revenue for the last quarter?

What is Afya Ltd (AFYA)'s earnings per share (EPS) for the last quarter?

What changes have occurred in the market's expectations for Afya Ltd (AFYA)'s fundamentals?

How many employees does Afya Ltd (AFYA). have?
